Gemzel Hernandez

570 total citations
10 papers, 393 citations indexed

About

Gemzel Hernandez is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Gemzel Hernandez has authored 10 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Physiology and 2 papers in Epidemiology. Recurrent topics in Gemzel Hernandez's work include Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Respiratory Support and Mechanisms (3 papers) and Asthma and respiratory diseases (3 papers). Gemzel Hernandez is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Respiratory Support and Mechanisms (3 papers) and Asthma and respiratory diseases (3 papers). Gemzel Hernandez collaborates with scholars based in United States, United Kingdom and Venezuela. Gemzel Hernandez's co-authors include Yolanda de la Llave, Diego García‐Borreguero, Oscar Larrosa, X. Masramón, Naitee Ting, R Abrahams, Richard ZuWallack, Alexander Michel, David Vizcaya and Lin Li and has published in prestigious journals such as Neurology, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Gemzel Hernandez

9 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gemzel Hernandez United States 5 232 199 185 113 73 10 393
Irene Cano‐Pumarega Spain 13 289 1.2× 282 1.4× 239 1.3× 128 1.1× 249 3.4× 45 609
Zhuonan Wang China 12 114 0.5× 106 0.5× 113 0.6× 50 0.4× 22 0.3× 25 354
R. John Kimoff Canada 10 58 0.3× 115 0.6× 52 0.3× 75 0.7× 245 3.4× 24 441
Liyan Lu China 13 156 0.7× 166 0.8× 116 0.6× 29 0.3× 18 0.2× 34 395
Valerie Lohner Germany 10 75 0.3× 37 0.2× 73 0.4× 82 0.7× 59 0.8× 25 379
Aad van der Lugt Netherlands 10 127 0.5× 41 0.2× 54 0.3× 57 0.5× 30 0.4× 17 251
Tom J. Moullaali United Kingdom 13 330 1.4× 48 0.2× 380 2.1× 28 0.2× 18 0.2× 26 537
C. von Schéele Sweden 10 102 0.4× 80 0.4× 116 0.6× 39 0.3× 16 0.2× 20 308
Frank G. van Rooij Netherlands 7 129 0.6× 38 0.2× 93 0.5× 70 0.6× 15 0.2× 16 317
E. Ott Austria 10 59 0.3× 40 0.2× 115 0.6× 30 0.3× 46 0.6× 24 279

Countries citing papers authored by Gemzel Hernandez

Since Specialization
Citations

This map shows the geographic impact of Gemzel Hernandez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemzel Hernandez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemzel Hernandez more than expected).

Fields of papers citing papers by Gemzel Hernandez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gemzel Hernandez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemzel Hernandez. The network helps show where Gemzel Hernandez may publish in the future.

Co-authorship network of co-authors of Gemzel Hernandez

This figure shows the co-authorship network connecting the top 25 collaborators of Gemzel Hernandez. A scholar is included among the top collaborators of Gemzel Hernandez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gemzel Hernandez. Gemzel Hernandez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Mathews, Kusum S., et al.. (2025). Improved lung function with beclomethasone/formoterol versus beclomethasone alone in asthma: the FORCE2 study. Journal of Asthma. 63(3). 305–311.
2.
Li, Lin, Susan S. Jick, Stefanie Breitenstein, et al.. (2016). Pulmonary arterial hypertension in the USA: an epidemiological study in a large insured pediatric population. Pulmonary Circulation. 7(1). 126–136. 51 indexed citations
3.
Moretz, Chad, Yunping Zhou, Amol D. Dhamane, et al.. (2015). Development and Validation of a Predictive Model to Identify Individuals Likely to Have Undiagnosed Chronic Obstructive Pulmonary Disease Using an Administrative Claims Database. Journal of Managed Care & Specialty Pharmacy. 21(12). 1149–1159. 8 indexed citations
8.
O’Donnell, Denis E., François Maltais, János Pórszász, et al.. (2012). Lung Function And Exercise Impairment In Patients With GOLD Stage I And II COPD. A6400–A6400. 4 indexed citations
9.
Hernandez, Gemzel, et al.. (2006). Desloratadine is Safe and Effective in the Treatment of the Nasal Symptoms of Perennial Allergic Rhinitis (PAR): Results of Two Observational Studies. Journal of Allergy and Clinical Immunology. 117(2). S320–S320. 1 indexed citations
10.
García‐Borreguero, Diego, et al.. (2002). Treatment of restless legs syndrome with gabapentin. Neurology. 59(10). 1573–1579. 273 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026